Plasma Therapy Market by Type, Application

List of Tables

The Plasma Therapy Market was valued at USD 359.73 million in 2023, expected to reach USD 389.19 million in 2024, and is projected to grow at a CAGR of 11.73%, to USD 781.95 million by 2030.

Plasma therapy, especially in the context of convalescent plasma therapy, involves the transfusion of plasma from individuals who have recovered from infections. The scope of plasma therapy extends to its application in treating viral infections by utilizing neutralizing antibodies present in the plasma. It is a crucial therapeutic tool, particularly for disease outbreaks where specific treatments or vaccines are unavailable. The application spans convalescent plasma therapy, immunoglobulin therapy, and therapeutic plasma exchange, with end-use mainly in hospitals, academic research institutes, and therapeutic centers. The market is driven by rising incidences of autoimmune diseases and the increased necessity for improved treatments for life-threatening viral infections like COVID-19. Additionally, the aging population presents a continuous influx of plasma donors, thereby facilitating market expansion. Advancements in research and technology promise new market opportunities, inviting innovation in plasma collection and storage techniques to enhance efficacy and safety. However, the market faces substantial challenges such as regulatory uncertainties, risks of transfusion-transmitted infections, and logistical hurdles in plasma supply and demand balance. A significant barrier remains the standardization of therapies, which can lead to varied treatment outcomes. Innovating within this market could involve developing automated devices for efficient plasma separation and processing. Research could also target genetic engineering to enhance plasma efficacy. Collaborations across academic, clinical, and industry stakeholders could accelerate the development of new protocols and the identification of novel plasma-use-cases. These efforts will drive market competitiveness and broaden therapeutic options. The plasma therapy market is thus dynamic, with potential growth tempered by logistical and regulatory complexities. Emphasizing innovation and strategic partnerships can provide a pathway to overcoming these barriers and exploiting new growth opportunities.

KEY MARKET STATISTICS
Base Year [2023]	USD 359.73 million
Estimated Year [2024]	USD 389.19 million
Forecast Year [2030]	USD 781.95 million
CAGR (%)	11.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Plasma Therapy Market

The Plasma Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Prevalence of infectious and chronic diseases worldwide
- Inclination towards early diagnosis and treatment of diseases
- Increase in number of clinical trials to test efficacy of plasma therapy
Market Restraints
- High cost of plasma therapy treatment
Market Opportunities
- Advancements in platelet-rich plasma therapy
- Emerging use of plasma therapy in dermatology
Market Challenges
- Adverse effects associated with the plasma therapy

Porter's Five Forces: A Strategic Tool for Navigating the Plasma Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Plasma Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Plasma Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Plasma Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Plasma Therapy Market

A detailed market share analysis in the Plasma Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Plasma Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Plasma Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Plasma Therapy Market

A strategic analysis of the Plasma Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Plasma Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., ADMA Biologics, Inc., Arthrex, Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Exactech Inc., GC Pharma, Global Stem Cells Group, Inc., Green Cross Corporation, Grifols, S.A., Hualan Biological Engineering Inc., Interstate Blood Bank, Inc., Japan Blood Products Organization, Johnson & Johnson Services, Inc., Kedrion S.p.A., LFB S.A., Octapharma AG, Regen Lab SA, Shanghai RAAS Blood Products Co., Ltd., Stryker Corporation, Takeda Pharmaceutical Company Limited, Terumo Corporation, and Zimmer Biomet Holdings, Inc.

Market Segmentation & Coverage

This research report categorizes the Plasma Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF), and Pure PRP.
Based on Application, market is studied across Dental, Dermatology, Nerve Injury, and Orthopedics.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-DD0700E81E9A

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Prevalence of infectious and chronic diseases worldwide
  - 5.1.1.2. Inclination towards early diagnosis and treatment of diseases
  - 5.1.1.3. Increase in number of clinical trials to test efficacy of plasma therapy
- 5.1.2. Restraints
  - 5.1.2.1. High cost of plasma therapy treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in platelet-rich plasma therapy
  - 5.1.3.2. Emerging use of plasma therapy in dermatology
- 5.1.4. Challenges
  - 5.1.4.1. Adverse effects associated with the plasma therapy
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Plasma Therapy Market, by Type

6.1. Introduction
6.2. Leucocyte-rich PRP
6.3. Leukocyte-rich Fibrin (L-PRF)
6.4. Pure Platelet-rich Fibrin (PRF)
6.5. Pure PRP

7. Plasma Therapy Market, by Application

7.1. Introduction
7.2. Dental
7.3. Dermatology
7.4. Nerve Injury
7.5. Orthopedics

8. Americas Plasma Therapy Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Plasma Therapy Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Plasma Therapy Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abeona Therapeutics Inc.
2. ADMA Biologics, Inc.
3. Arthrex, Inc.
4. Bio Products Laboratory Ltd.
5. Biotest AG
6. China Biologic Products, Inc.
7. CSL Limited
8. Emergent BioSolutions Inc.
9. Exactech Inc.
10. GC Pharma
11. Global Stem Cells Group, Inc.
12. Green Cross Corporation
13. Grifols, S.A.
14. Hualan Biological Engineering Inc.
15. Interstate Blood Bank, Inc.
16. Japan Blood Products Organization
17. Johnson & Johnson Services, Inc.
18. Kedrion S.p.A.
19. LFB S.A.
20. Octapharma AG
21. Regen Lab SA
22. Shanghai RAAS Blood Products Co., Ltd.
23. Stryker Corporation
24. Takeda Pharmaceutical Company Limited
25. Terumo Corporation
26. Zimmer Biomet Holdings, Inc